IP Verse

Memorial Sloan Kettering Cancer Center patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Memorial Sloan Kettering Cancer Center opposed by its competitors

Explore Memorial Sloan Kettering Cancer Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3217983
May 1, 2024Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/Ceramide Pathway Through Timed Administration Of A Short-Acting Anti-Angiogenic Agent1
EP3686290
Aug 23, 2023Method And Kits For Identifying Of Cdk9 Inhibitors For The Treatment Of Cancer1
EP3065777
Jul 12, 2023Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease1
EP2981607
Aug 19, 2020Effective Generation Of Tumor-Targeted T-Cells Derived From Pluripotent Stem Cells2
EP2773748
Dec 25, 2019Midbrain Dopamine (Da) Neurons For Engraftment1
EP2482849
Jun 6, 2018Combination Immunotherapy For The Treatment Of Cancer2

Top competitors of Memorial Sloan Kettering Cancer Center

List of top competitors of Memorial Sloan Kettering Cancer Center based on patent oppositions.